TVP与经尿道双极等离子电切术治疗良性前列腺增生的临床效果

Clinical effect of TVP and transurethral plasmakinetic resection of prostate in the treatment of benign prostatic hypertrophy

目的探讨经尿道前列腺汽化电切术(TVP)与经尿道双极等离子电切术治疗良性前列腺增生的临床效果。方法将我院收治100例良性前列腺增生症患者按照随机表原则分为对照组与观察组,各50例。对照组采用TVP治疗,观察组采用经尿道双极等离子电切术治疗。比较两组的治疗效果。结果治疗后,两组的最大尿流率、PGI2水平、IIEF-5、CIPE-5评分均升高,残余尿量减少,IPSS及QOL评分、PSA水平均降低,且观察组优于对照组(P<0.05)。结论经尿道双极等离子电切术治疗良性前列腺增生安全可靠,可显著提高患者生活质量。

Objective To observe the clinical effect of transurethral vapo-resection of prostate(TVP) and transurethral plasmakinetic resection of prostate in the treatment of benign prostatic hypertrophy. Methods A total of 100 cases of benign prostatic hypertrophy admitted in our hospital were divided into control group and observation group according to the random table principle, with 50 cases in each group. The control group was treated with TVP, and the observation group was treated with transurethral plasmakinetic resection of prostate. The therapeutic effects of the two groups were compared.Results After treatment, the maximum urine flow rates, PGI2 levels, scores of IIEF-5 and CIPE-5 in the two groups increased, the residual urine volume, scores of IPSS, QOL and PSA levels decreased, and those in the observation group were better than the control group(P <0.05). Conclusion Transurethral plasmakinetic resection of prostate is safe and reliable in the treatment of benign prostatic hypertrophy, which can significantly improve the quality of life of patients.